CBC
Cannabichromene

How it occurs

Derived from CBCA and usually found in smaller quantities than THC or CBD.

Relationship to other cannabinoids

Neutral product of CBCA and distinct from CBD, THC, and CBG.

What is established

CBC is a naturally occurring cannabinoid studied in preclinical models.

Commonly reported effects

Consumer-effect reports are sparse and not sufficient for firm claims.

Anecdotal or marketing-led unless stated otherwise

What remains uncertain

There is not enough human evidence to support broad health claims.

Evidence quality

Mostly preclinical.

Safety and potential interactions

Clinical dosing, interactions, and long-term safety are not well established.

Vaporization relevance

Heating can change cannabinoid form and delivery, but laboratory boiling points do not define a universal device setting. Heater design, sensor position, airflow, material, load, and draw behavior all affect exposure. This entry makes no compound-specific temperature recommendation.

Legal and regulatory context

Depends on source, product formulation, claims, and jurisdiction.

Dated source foundation

Direct authoritative sources reviewed 2026-08-20. These sources support the safety and regulatory boundaries of this draft; a scientific editor must still verify compound-specific claims against current peer-reviewed literature.

• FDA — Cannabis and cannabis-derived products: questions and answers ↗
• FDA — What to know about cannabis and CBD products ↗
• NIDA — Cannabis (Marijuana) ↗
• CDC — Cannabis frequently asked questions ↗

Related entries

CBGA · CBG

← All encyclopedia entries